Why Wegovy May Feel Like It Wears Off Towards the End of the Week

Semaglutide's half-life is approximately seven days, so blood levels peak early in the week and fall before the next dose is due.
Hunger returning towards day six or seven is a recognised pharmacological pattern, not a sign treatment has stopped working.
Steady-state blood levels build over several weeks of consistent weekly injections, often reducing the end-of-week dip over time.
Missing or delaying an injection amplifies the trough effect — consistency matters more than timing adjustments.

Many people taking Wegovy notice that appetite suppression feels strongest in the first few days after an injection, then gradually softens by day six or seven. This is a real pharmacological pattern, not imagination. Semaglutide has a half-life of roughly seven days, meaning its concentration in your blood is declining throughout the week even as you build towards the next dose. The medicines pages on the NHS semaglutide resource confirm the once-weekly schedule, and the pattern most people notice maps closely onto that half-life curve. Wegovy is a prescription-only medicine, and how it is affecting you at different points in your cycle is something your prescriber can help you interpret and manage.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the pharmacology and clinical evidence tell us about end-of-week appetite changes on Wegovy

What semaglutide's half-life actually means for how you feel day to day

The STEP 1 trial, published in the New England Journal of Medicine, established semaglutide 2.4mg as producing around 15% average body-weight reduction over 68 weeks. What those headline figures can obscure is that semaglutide's effects are not a flat, steady experience across every day of treatment. Semaglutide has a pharmacokinetic half-life of approximately seven days. In plain terms, the amount of the medicine circulating in your blood roughly halves every week. After your injection on, say, Monday, levels rise over the following day or two, reach a peak, and then begin a gradual decline. By Sunday, you are at the lowest point of your dosing cycle.

This matters because semaglutide's appetite-suppressing effects are concentration-dependent. The GLP-1 receptor agonism that slows gastric emptying and reduces hunger signals is stronger when blood levels are higher. As levels fall towards the end of the seven-day window, some people notice that hunger feels more insistent, food is harder to ignore, and the quiet fullness they experienced earlier in the week has receded. That experience is consistent with what the pharmacology would predict. It is not a failure of the medicine; it is the medicine behaving as designed.

Crucially, the effect tends to become less pronounced with time. Semaglutide accumulates to a steady state over roughly four to five weeks of regular weekly dosing, which means the trough at the end of week one is shallower than the trough at the end of week five or week ten. Patience and consistency are both doing real work here. For a fuller picture of how semaglutide compares across the dosing week, the detailed look at how effects change across the week explores the concentration curve more closely.

Why some weeks feel sharper than others — and what changes this

Not everyone notices the end-of-week pattern to the same degree, and the factors that influence it are worth understanding. Injection timing consistency is probably the most important. If your usual injection day shifts (you take it a day late one week, a day early the next) your trough and your peak move around with it, making the cycle harder to adapt to. Sticking to the same day each week is the most straightforward way to stabilise the pattern.

Dose level also plays a role. People on lower doses in the titration schedule often report the dip more acutely, partly because the overall concentration throughout the week is lower. As the dose increases towards the 2.4mg maintenance level, the absolute amount of semaglutide in circulation at the trough rises too. This is one reason the titration schedule exists: the body adapts incrementally, and the therapeutic effect broadens as doses increase. The experience around week five is worth reading if you are in the earlier phases of treatment.

Lifestyle factors interact with the pattern too. Sleep quality, stress levels, and how much protein you are eating all influence how hunger is perceived and tolerated. Some people find that structuring more filling, protein-forward meals on their end-of-week days helps bridge the dip in a practical way. That kind of adjustment is worth raising with your prescriber, who can advise based on your full clinical picture. The broader question of whether semaglutide wears off within the week covers these variables in more depth.

When to raise the end-of-week pattern with your prescriber

Noticing a dip in the last day or two before your next injection is common and does not on its own indicate that treatment needs to change. However, there are situations where it is worth flagging. If the end-of-week hunger has become severe enough to undo most of the progress made earlier in the week, or if you are consistently struggling to keep to your dietary goals on days six and seven, your prescriber may want to review whether the current dose is still the right one.

It is also worth mentioning if the pattern has changed suddenly after weeks of being stable. A significant worsening of the trough effect can occasionally reflect other factors, including missed or late injections, a storage issue affecting the medicine itself, or something unrelated to Wegovy. Each Wegovy pen should be kept refrigerated at 2 to 8°C until use; if a pen has been stored outside that range, the medicine may have degraded. The Patient Information Leaflet supplied with your pen gives the full storage guidance and is the definitive reference for these details.

If you are getting treatment through a regulated online pharmacy, your prescriber is there for exactly these conversations. At nume, a GPhC-registered prescriber reviews every consultation and every repeat order personally. There is no queue for an automated system. Questions like this one are what clinical review is for. For anything that does not feel right between your weekly doses, contacting the aftercare team directly is always the right move.

The question this raises about taking a break or changing injection day

It is natural to wonder, once you notice the weekly cycle, whether adjusting the timing of your injection might help, moving it to a different day, or taking a short break to see how you feel. The evidence here is fairly clear. Wegovy is designed to maintain a consistent weekly rhythm; disrupting that rhythm deepens and prolongs the trough rather than flattening it. The specific question of whether skipping a week is advisable is answered in more detail, but the short version is that most prescribers do not recommend breaks except for clinical reasons.

Changing injection day, by contrast, is sometimes possible and relatively straightforward to manage, provided the gap between doses does not drop below four days or extend significantly beyond seven. Your prescriber can advise whether a timing shift makes sense given where you are in treatment. This is not something to adjust unilaterally.

For anyone who is considering Wegovy and wondering what to expect week to week, the Wegovy overview covers the full picture, from how the titration schedule works to what eligibility looks like. Practical information on accessing treatment privately is on the Wegovy access page, including what the process involves at a regulated UK pharmacy. If you are ready to take the next step, checking your eligibility with a free consultation is the starting point, reviewed the same day by a real prescriber, dispatched the same working day once approved, and delivered by DPD in plain packaging to your door.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions